References

Prevalence of dementia in the United States: the aging, demographics, and memory study

10.1159/000109998 · 2007 · External reference

Decreased myelin lipids in alzheimer's disease and vascular dementia

10.1111/j.1600-0404.1989.tb03886.x · 1989 · External reference

10.1212/wnl.43.2.250

10.1212/wnl.43.2.250 · External reference

10.1375/twin.12.6.573

10.1375/twin.12.6.573 · External reference

A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms

10.1002/ana.24758 · 2016 · External reference

10.1016/j.jalz.2017.01.008

10.1016/j.jalz.2017.01.008 · External reference

Optimizing the lipidomics workflow for clinical studies–practical considerations

10.1007/s00216-015-8633-2 · 2015 · External reference

Plasma lipidome variation during the second half of the human lifespan is associated with age and sex but minimally with bmi

10.1371/journal.pone.0214141 · 2019 · External reference

10.18637/jss.v033.i01

10.18637/jss.v033.i01 · External reference

A language and environment for statistical

2018 · External reference

Unresolved reference

External reference

Proc: an open-source package for r and s+ to analyze and compare roc curves

10.1186/1471-2105-12-77 · 2011 · External reference

10.1093/biomet/78.3.691

10.1093/biomet/78.3.691 · External reference

Coefficients of determination in logistic regression models—a new proposal: the coefficient of discrimination

10.1198/tast.2009.08210 · 2009 · External reference

Sphingolipids: membrane microdomains in brain development, function and neurological diseases

2017 · External reference

10.1371/journal.pmed.1002482

10.1371/journal.pmed.1002482 · External reference

Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics

10.1371/journal.pone.0021643 · 2011 · External reference

10.1007/s12017-010-8121-y

10.1007/s12017-010-8121-y · External reference

Role of cholesterol and sphingolipids in brain development and neurological diseases

10.1186/s12944-019-0965-z · 2019 · External reference

10.1016/j.neurobiolaging.2014.02.025

10.1016/j.neurobiolaging.2014.02.025 · External reference

10.1161/01.atv.20.12.2614

10.1161/01.atv.20.12.2614 · External reference

10.1128/mcb.05893-11

10.1128/mcb.05893-11 · External reference

Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and ldl aggregation in ldlr-/- mice fed on a high-fat diet

10.1042/bsr20120036 · 2012 · External reference

Diverse biological functions of sphingolipids in the cns: ceramide and sphingosine regulate myelination in developing brain but stimulate demyelination during pathogenesis of multiple sclerosis

2017 · External reference

Decreased ceramide underlies mitochondrial dysfunction in charcot-marie-tooth 2f

10.1096/fj.201701067r · 2018 · External reference

10.1074/jbc.m112.402719

10.1074/jbc.m112.402719 · External reference

Inferior prefrontal cortex mediates the relationship between phosphatidylcholine and executive functions in healthy, older adults

2016 · External reference

10.1074/jbc.m112.445734

10.1074/jbc.m112.445734 · External reference

Converging and differential brain phospholipid dysregulation in the pathogenesis of repetitive mild traumatic brain injury and Alzheimer's disease

10.3389/fnins.2019.00103 · 2019 · External reference

Application of metabolomics in Alzheimer's disease

10.3389/fneur.2017.00719 · 2017 · External reference

10.1021/cr200085w

10.1021/cr200085w · External reference

10.1016/j.bbamem.2008.07.027

10.1016/j.bbamem.2008.07.027 · External reference

Phospholipases a2 and inflammatory responses in the central nervous system

10.1007/s12017-009-8092-z · 2010 · External reference

Intracellular- and extracellular-derived ca(2+) influence phospholipase a(2)-mediated fatty acid release from brain phospholipids

10.1016/j.bbalip.2009.03.009 · 2009 · External reference

10.1074/jbc.m115.706523

10.1074/jbc.m115.706523 · External reference

10.1074/jbc.m109.023846

10.1074/jbc.m109.023846 · External reference

Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus

10.1093/jn/135.5.1008 · 2005 · External reference

Pip2: a new key player in Alzheimer's disease

2008 · External reference

10.1111/j.1753-4887.2010.00344.x

10.1111/j.1753-4887.2010.00344.x · External reference

10.1038/nm.3466

10.1038/nm.3466 · External reference

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease

10.1038/tp.2014.127 · 2015 · External reference

Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now?

10.1016/j.tips.2011.07.004 · 2011 · External reference

10.3233/jad-150336

10.3233/jad-150336 · External reference

10.1016/j.tibs.2006.11.004

10.1016/j.tibs.2006.11.004 · External reference

10.1371/journal.pone.0077983

10.1371/journal.pone.0077983 · External reference

10.1074/jbc.m111.274142

10.1074/jbc.m111.274142 · External reference

Plasma diacylglycerol composition is a biomarker of metabolic syndrome onset in rhesus monkeys

10.1194/jlr.m057562 · 2015 · External reference

Metformin, lifestyle intervention, and cognition in the diabetes prevention program outcomes study

10.2337/dc16-2376 · 2017 · External reference

Triglycerides are negatively correlated with cognitive function in nondemented aging adults

10.1037/neu0000335 · 2017 · External reference

Metabolic cardiovascular syndrome and risk of dementia in japanese-american elderly men. The honolulu-asia aging study

10.1161/01.atv.20.10.2255 · 2000 · External reference

Triglyceride and hdl-c dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study

10.2337/dc16-1958 · 2017 · External reference

Involvement of neutral sphingomyelinase in the angiotensin ii signaling pathway

10.1152/ajprenal.00079.2014 · 2015 · External reference

The role of ceramides in insulin resistance

10.3389/fendo.2019.00577 · 2019 · External reference

10.1371/journal.pone.0021817

10.1371/journal.pone.0021817 · External reference

Cholesteryl ester transfer protein (cetp), hdl capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure

10.1186/s12944-018-0888-0 · 2018 · External reference

Increased serum cholesterol esterification rates predict coronary heart disease and sudden death in a general population

10.1161/atvbaha.113.301297 · 2013 · External reference

Lysophosphatidylcholine inhibits receptor-mediated ca2+ mobilization in intact endothelial cells of rabbit aorta

10.1161/01.atv.17.8.1561 · 1997 · External reference

Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes

10.1371/journal.pone.0041456 · 2012 · External reference

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies

10.1186/s12933-018-0763-3 · 2018 · External reference

Lipids and cerebrovascular disease: research and practice

10.1161/strokeaha.115.011164 · 2015 · External reference

Plasma lipids and cerebral small vessel disease

10.1212/wnl.0000000000000980 · 2014 · External reference

Plasma lipid profiling identifies biomarkers of cerebral microvascular disease

10.3389/fneur.2019.00950 · 2019 · External reference

Deregulation of sphingolipid metabolism in Alzheimer's disease

10.1016/j.neurobiolaging.2008.05.010 · 2010 · External reference

10.3390/ijms14011310

10.3390/ijms14011310 · External reference

cerebrovascular disease in the elderly people

10.3143/geriatrics.43.152 · 2006 · External reference